Abstract:Protein inclusions containing phosphorylated TDP-43 are a shared pathology in several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, most ALS/FTD patients do not have a mutation in TDP-43 or the enzymes directly regulating its phosphorylation. It is intriguing how TDP-43 becomes hyperphosphorylated in each disease condition. In a genetic screen for novel TDP-43 modifiers, we found that knockdown (KD) of CHMP2B , a key component of the endosomal sorting complex required for transport (ESCRT) machinery, suppressed TDP-43-mediated neurodegeneration in Drosophila . Further investigation using mammalian cells indicated that CHMP2B KD decreased whereas its overexpression (OE) increased TDP-43 phosphorylation levels. Moreover, a known FTD-causing mutation CHMP2B intron5 promoted hyperphosphorylation, insolubility and cytoplasmic accumulation of TDP-43. Interestingly, CHMP2B did not manifest these effects by its well-known function in the autophagy-lysosomal pathway. Instead, the kinase CK1 tightly regulated TDP-43 phosphorylation level in cells, and CHMP2B OE or CHMP2BIntron5 significantly decreased ubiquitination and the turnover of CK1 via the ubiquitin-proteasome (UPS) pathway. Finally, we showed that CHMP2B protein levels increased in the cerebral cortices of aged mice, which might underlie the age-associated TDP-43 pathology and disease onset. Together, our findings reveal a molecular link between the two ALS/FTD-pathogenic proteins CHMP2B and TDP-43, and provide an autophagy-independent mechanism for CHMP2B in pathogenesis. SIGNIFICANCE STATEMENT TDP-43 and CHMP2B are both ALS/FTD-associated proteins. Protein aggregations containing phosphorylated TDP-43 are a pathological hallmark of ALS/FTD; however, it is unclear how increased phosphorylation of TDP-43 occurs in diseases. The pathogenesis of CHMP2B has mainly been considered as a consequence of autophagy-lysosomal dysfunction. Here, we reveal that increase of CHMP2B levels (which occurs in aged mouse brains) or expression of the disease-causing mutation CHMP2BIntron5 promotes TDP-43 hyperphosphorylation, insolubility and cytoplasmic mislocalization. This effect is independent of the autophagy-lysosomal pathway but rather relies on the proteasome-mediated turnover of the kinase CK1 that phosphorylates TDP-43. Together, we provide a new molecular mechanism of CHMP2B pathogenesis by linking it to TDP-43 pathology via CK1. ### Competing Interest Statement The authors have declared no competing interest.

Structural and functional studies of TBC1D23 C-terminal domain provide a link between endosomal trafficking and PCH.

FAM91A1-TBC1D23 Complex Structure Reveals Human Genetic Variations Susceptible for PCH

TBC1D23 mediates Golgi-specific LKB1 signaling

A Familial Late-Onset Hereditary Ataxia Mimicking Pontocerebellar Hypoplasia Caused by A Novel Tsen54 Mutation

Structure of TBC1D23 N-terminus reveals a novel role for rhodanese domain

CRL4 Antagonizes SCFFbxo7-mediated Turnover of Cereblon and BK Channel to Regulate Learning and Memory

A Long Type of TBCK is a Novel Cytoplasmic and Mitotic Apparatus-Associated Protein Likely Suppressing Cell Proliferation.

Golgi damage caused by dysfunction of PiT-2 in primary familial brain calcification

Modulation of Synaptic Plasticity, Motor Unit Physiology, and TDP-43 Pathology by CHCHD10.

Structure of the TBC1D7-TSC1 Complex Reveals That TBC1D7 Stabilizes Dimerization of the TSC1 C-terminal Coiled Coil Region.

KCTD10 P.c124w Variant Contributes to Schizophrenia by Attenuating LLPS-mediated Synapse Formation.

TAD boundary deletion causes PITX2-related cardiac electrical and structural defects

PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/BNIP3L-dependent mitophagy

Ptpn23 Controls Cardiac T-Tubule Patterning by Promoting the Assembly of Dystrophin-Glycoprotein Complex

CHMP2B Regulates TDP-43 Phosphorylation and Proteotoxicity Via Modulating CK1 Turnover Independent of the Autophagy-Lysosomal Pathway

Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity

Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction

GTPase-activating Protein TBC1D5 Coordinates with Retromer to Constrain Synaptic Growth by Inhibiting BMP Signaling

Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia

CTCF mutation at R567 causes developmental disorders via 3D genome rearrangement and abnormal neurodevelopment

TSEN54 mutations cause pontocerebellar hypoplasia type 5